Prenatal testing guide — decision hub · 2026
This is the page that puts the others in order. The most useful question is not which test is best, but what you would do with each possible answer.
By MedEx · Updated September 2026 · Approx. 10-minute read
Quick answer
Prenatal testing in Thailand has four strands, and they answer different questions. Ultrasound assesses structure and dating. Screening (NIPT, combined screening) estimates the chance of specific chromosomal conditions. Diagnosis (CVS, amniocentesis) establishes them definitively. Carrier screening — above all thalassaemia in the Thai population — addresses single-gene conditions that none of the others cover. Declining any of these is a legitimate choice. The most useful preparation is deciding, in advance, what you would do with each possible result.
In this guide
| Ultrasound | Structure, dating, viability, number of fetuses — not replaceable by any blood test |
|---|---|
| Screening | NIPT or combined screening — estimates probability |
| Diagnosis | CVS or amniocentesis — establishes a diagnosis |
| Carrier screening | Thalassaemia and other single-gene conditions |
| Also valid | Declining testing, if a result would not change your decisions |
| Counselling | Doctor consultation or specialist teleconsultation before and after testing |
The timeline
| Before conception | Carrier screening (thalassaemia first in Thailand), rubella immunity, hepatitis B, thyroid function, full blood count and ferritin, folic acid, medication review. |
|---|---|
| 6–10 weeks | Dating scan: viability, gestational age, number of fetuses, chorionicity. |
| From 10 weeks | NIPT, if you want it. |
| 10–13 weeks | CVS, if diagnostic testing is indicated. |
| 11–14 weeks | Nuchal translucency scan and, where used, PAPP-A and free beta-hCG. |
| From 15 weeks | Amniocentesis, if diagnostic testing is indicated. |
| 18–22 weeks | Anomaly scan — the detailed structural examination. Not optional. |
| 24–28 weeks | Gestational diabetes screening; antibody screening. |
| Third trimester | Growth scans where indicated; Group B strep screening at around 36–37 weeks where used. |
Deciding what you actually want
The most useful preparation is not comparing test specifications. It is answering three questions honestly, before the first blood draw:
- What would I do with a high-risk result? If the answer is “have diagnostic testing and then decide”, screening is useful. If the answer is “nothing would change”, screening may add anxiety without adding value — and declining is entirely reasonable.
- How do I handle uncertainty? Screening produces probabilities, and false positives are a real feature. Some people find intermediate information helpful; others find it corrosive. Both responses are normal.
- Would I accept an invasive procedure? If not, a high-risk screening result cannot be resolved, and you will be left with an unresolvable probability for the rest of the pregnancy. That is worth knowing before starting.
There is no medically correct answer to any of these. A pre-test conversation is the right place to work through them — book a doctor consultation or a specialist teleconsultation.
Decide what you want to know before booking, not after a result arrives.
Common situations
Low risk, wanting reassurance without procedural risk. Dating scan, NIPT from 10 weeks, NT scan, anomaly scan. Carrier screening if not already done.
Advanced maternal age. Same pathway, but the positive predictive value of NIPT is higher, which makes a high-risk result more likely to be genuine. See the accuracy guide.
Previous affected pregnancy. Discuss diagnostic testing directly, since prior risk is elevated and screening may not add enough.
Structural abnormality on ultrasound. Diagnostic testing with chromosomal microarray, not NIPT — NIPT does not cover most of what could explain a structural finding.
Known familial genetic condition. Targeted diagnostic testing through genetic services; NIPT does not cover single-gene conditions.
Both partners thalassaemia carriers. Genetic counselling and consideration of prenatal diagnosis — see the thalassaemia guide.
Twins or IVF. Additional considerations apply — see the twins and IVF guide.
Choosing not to test. Ultrasound for dating and structural assessment, and routine antenatal care, without chromosomal screening. This is a legitimate, informed choice.
The gaps nobody mentions
Even a complete pathway leaves gaps, and knowing them prevents misplaced confidence:
- No test predicts developmental or intellectual outcome.
- Most single-gene conditions are not screened for unless specifically tested.
- Ultrasound detection is incomplete — some conditions develop later, some are not visible, and image quality varies.
- NIPT covers a short list, not all chromosomal conditions.
- Many childhood conditions are not genetic and could not be detected prenatally by any means.
The honest summary: prenatal testing substantially reduces uncertainty about a specific set of conditions. It does not eliminate uncertainty about a pregnancy, and no combination of tests ever will.
To arrange any part of the pathway — NIPT, imaging, genetic testing or antenatal bloods — the team can plan it around your gestation and priorities.
Frequently asked questions
What prenatal tests are available in Thailand?
Ultrasound for dating, nuchal translucency and structural assessment; screening by NIPT or first trimester combined screening; diagnosis by chorionic villus sampling or amniocentesis; and carrier screening for single-gene conditions, above all thalassaemia.
Do I have to have prenatal screening?
No. Declining chromosomal screening is a legitimate, informed choice, particularly if a result would not change your decisions. Ultrasound for dating and structural assessment remains part of routine antenatal care.
What should I decide before testing?
What you would do with a high-risk result, how you handle uncertainty, and whether you would accept an invasive diagnostic procedure. If you would not, a high-risk screening result cannot be resolved.
Which test should I have if an abnormality is seen on ultrasound?
Diagnostic testing with chromosomal microarray, rather than NIPT. NIPT does not cover most of the conditions that could explain a structural finding.
Does prenatal testing rule out all problems?
No. No test predicts developmental outcome, most single-gene conditions are not screened for unless specifically tested, ultrasound detection is incomplete, and many childhood conditions are not genetic at all.
When should carrier screening be done?
Before conception where possible, since that gives the widest range of options. In Thailand thalassaemia screening is the highest priority given how common carriage is.
Ready to book? Every part of the pathway is available through MedEx.
Sources and further reading
- ACOG Practice Bulletin: Screening for Fetal Chromosomal Abnormalities
- ISUOG practice guidelines
- MedEx NIPT service
- MedEx genetic testing services
Medical disclaimer: This article is general health information and does not replace medical advice, diagnosis or treatment. Laboratory reference ranges differ between laboratories and results must be interpreted alongside your symptoms, medicines and medical history. Speak with a qualified clinician before starting, stopping or changing any treatment. Service details, inclusions and prices can change — confirm them with MedEx before booking.
